iHuman (NYSE:IH) Trading 0.4% Higher – What’s Next?

iHuman Inc. Sponsored ADR (NYSE:IHGet Free Report)’s share price shot up 0.4% during mid-day trading on Monday . The company traded as high as $1.40 and last traded at $1.3750. Approximately 2,443 shares changed hands during mid-day trading, a decline of 61% from the average daily volume of 6,304 shares. The stock had previously closed at $1.37.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of iHuman in a research note on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Get Our Latest Stock Analysis on IH

iHuman Stock Up 0.4%

The company’s fifty day moving average price is $1.49 and its 200 day moving average price is $1.71. The company has a market capitalization of $70.28 million, a P/E ratio of 7.24 and a beta of 0.15.

Hedge Funds Weigh In On iHuman

A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC acquired a new stake in iHuman Inc. Sponsored ADR (NYSE:IHFree Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 15,067 shares of the company’s stock, valued at approximately $32,000. 4.92% of the stock is owned by institutional investors.

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Further Reading

Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.